KLK3 and metastatic neoplasm: Although the incidence of early prostate cancer has risen dramatically through earlier detection following the introduction of prostate-specific antigen (PSA) testing, it is those cases presenting with locally advanced (M0) or metastatic disease (M1) who have the highest risk of progression and death.